• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; INTRODUCER, CATHETER Back to Search Results
Model Number 9610ES16
Device Problems Patient-Device Incompatibility (2682); Material Integrity Problem (2978)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/23/2022
Event Type  malfunction  
Event Description
Edwards received notification from our affiliate in spain.As reported, this was a case of an implant of 29mm edwards sapien 3 transcatheter heart valve, in aortic position by transfemoral approach.The patient had a history of severe aortic stenosis (as) and severe calcification and tortuosity in both iliac arteries.It was decided to access through the left femoral artery and a balloon pre-dilation was performed.During the introduction of the esheath it was not able to navigate.The sheath was removed and a new sheath was inserted.The valve was implanted successfully and the patient was stable.Post procedure images of the esheath were provided and showed a distal tip split.
 
Manufacturer Narrative
The investigation is in progress.A supplemental report will be submitted.
 
Manufacturer Narrative
The device was not returned for evaluation.Therefore, a no product return engineering evaluation was performed.A review of imagery was performed, and the following was observed: tortuosity present in patient's access vessel.Distal tip was open and split along the hdpe proximal to the axial score line.The device history record (dhr) review did not reveal any manufacturing nonconformance issues that would have contributed to the event.A lot history review was performed and revealed no other complaints relating to this event.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints of esheath distal tip split and sheath insertion inability were confirmed through evaluation of the imagery.As the device was not returned, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.Therefore, the presence of a manufacturing non-conformance was unable to be determined.However, review of the dhr, lot history, and complaint history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint event.A review of ifu/training materials revealed no deficiencies.Furthermore, there was no report of any issues with the sheath during device unpacking or preparation.As reported, ''the patient had severe aortic stenosis and severe calcification and tortuosity in both iliac arteries.It was decided to access through the left femoral artery and a bav was performed.Then, during the insertion of the esheath it was not possible to navigate.The esheath was removed, replaced with a new esheath which could be correctly inserted''.The patient was noted to have ''severe calcification and tortuosity''.Tortuous patient anatomy can also be observed in the returned patient imagery.The procedural training manual states, ''push force can vary due to angle of insertion, vessel diameter, tortuosity and degree of calcification''.It is likely that vessel calcification and tortuosity created a challenging pathway for sheath insertion through added friction from interaction with calcification and sub-optimal angles from tortuosity, which may have required additional force and device manipulation to overcome.Sheath interaction with calcification coupled with excessive manipulation can cause the sheath tip to split.As such available information suggests that patient (calcification, tortuosity) and/or procedural (excessive manipulation) factors may have contributed to the reported event.No labeling/ifu deficiencies were identified.Therefore, no corrective or preventative actions, nor product risk assessment (pra) is required at this time.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Manufacturer Narrative
Supplemental report submitted to include device return and evaluation.Updated h6 and h10.The returned device was visually inspected, and the following was observed: the sheath was unexpanded.The sheath distal tip was noted to be prematurely opened with the liner lifted near it.The sheath distal tip was split.Scratches along the shaft were noted.The complaints of esheath distal tip split and sheath insertion inability were confirmed through evaluation of the provided imagery and returned device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH INTRODUCER SET
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key14688722
MDR Text Key294578477
Report Number2015691-2022-06197
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K200258
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/12/2023
Device Model Number9610ES16
Device Catalogue NumberN/A
Device Lot Number64040159
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age71 YR
Patient SexMale
-
-